|
|
Other links at Articles > Dermatology |
| 1. |
Persistent Cutaneous Hyperpigmentation After Tyrosine Kinase Inhibition With Imatinib for GIST
|
|
|
Imatinib mesylate, a tyrosine kinase inhibitor, is an important part of the therapeutic armamentarium used in chronic myelogenous leukemia and gastrointestinal stromal tumors. Dermatological toxicities occur with the clinical use of this drug range from various acute rashes to Steven-Johnson syndrome. Hyperpigmentation of the skin is a less frequent side effect.
Dermatology Online Journal
|
| 2. |
Fleshy Lesions on a 32-Year-Old Woman
|
|
|
A 32-year-old woman presents to the emergency department (ED) with several flesh-colored papules and patches with well-defined borders on her face, trunk, and upper extremities. She first developed the lesions at 10 years of age. The patient’s medical and surgical history includes environmental allergies, frequent episodes of bronchitis, and excision of recurring skin papules. What is the diagnosis? eMedicine Case Presentations
|
| 4. |
Researchers Identify Melanoma-Initiating Cells
|
|
|
US researchers have identified cells responsible for initiating malignant melanoma and also found that therapeutic targeting of this cell subpopulation can inhibit tumor growth. Reuters Health Information
|
|
|
